Can a Smartphone Camera Detect Atrial Fibrillation?
An original study published in the Journal of the American Heart Association aimed at finding a novel method for screening patients for atrial fibrillation (AF) using an iPhone. It evaluated the…
Video Augmented Information Delivery to Patients Undergoing Elective PCI Enhances Patient Awareness and Satisfaction
A new multi-center prospective randomized trial published in the American Heart Journal was able to show that a video presentation may be better at helping patients to understand the procedure…
Delayed Coronary Obstruction: a post-TAVR Complication
A recently published study in the Journal of American College of Cardiology concluded that delayed coronary obstruction (DCO) occurring after transcatheter aortic valve replacement (TAVR) is an infrequent complication, associated…
High Sensitivity Troponin I and Stable Coronary Artery Disease
A recent study published in the Journal of American College of Cardiology found an association between elevated concentrations of high sensitivity troponin I (hsTnI) with increasing prevalence of coronary artery disease…
Tafamidis, A Real Hope for People with Transthyretin Cardiomyopathy?
On Thursday, March 29th, Pfizer announced positive topline results from ATTR-ACT trial of tafamidis in patients with transthyretin cardiomyopathy. According to Pfizer, “Tafamidis met its primary endpoint, demonstrating a statistically…
Assessment of Long-term Outcomes in Patients Undergoing SAVR
A contemporary cohort study recently published in Journal of the American College of Cardiology highlighted the clinical significance of age and other associated comorbidities in determining the clinical outcome in patients…
Does Operator PCI Volume Influence Mortality?
The number of procedures performed by the operator of a Percutaneous Coronary Intervention (PCI) in the previous year has no impact on the 30-day mortality, according to a recent UK…
Association of High-Sensitivity Cardiac Troponins (hs-cTn) and the Risk of New-onset Heart Failure
A recent study, published in the Journal of American College of Cardiology, concluded that there is a strong association of high sensitivity cardiac troponin (hs-cTn) with the risk of new-onset…
Role of Cholesterol Screening and Statin Therapy in Hypercholesterolemia
A nationally representative, cross-sectional study published in Circulation highlighted the importance of cholesterol screening and statin prescription in patients with familial hypercholesterolemia (FH) and other forms of severe dyslipidemia. It was…
Do Procedure and Coronary Lesion Characteristics Impact Clinical Outcomes in Atrial Fibrillation Patients Undergoing PCI?
According to a post-hoc analysis of the PIONEER AF-PCI trial that was recently published in the Journal of American College of Cardiology, there was no impact of complex coronary lesions,…
ICON RELOADED: A New Future for NT-proBNP
A multicenter, international, North American study published in the Journal of the American College of Cardiology has indicated that N-terminal pro–B-type natriuretic peptide (NT-proBNP) testing may be valuable in the…
SWAP 4 trial: De-escalation of P2Y12 Inhibitors
In a recent article published in The Circulation, it has been found that the use of a loading dose while switching between P2Y12 inhibitors in patients with coronary artery disease…
The ICON-RELOADED Study: A New Future for NT-proBNP
Dr. James Januzzi and Dr. C. Michael Gibson Discuss Subscribe on iTunes or Google Play.
HeartMate 3: Magnetic Pump in Advanced Heart Failure
According to a new study published in the New England Journal of Medicine, a fully magnetically levitated centrifugal- flow pump has been found to be superior to a mechanical-bearing axial-flow…
VEST: Wearable cardiac defibrillator decreases mortality post MI
The first randomized trial of the Wearable Cardiac Defibrillator (WCD) was conducted by Dr. Jeffrey Olgin and his colleagues from the University of California and presented at the ACC 2018…
Febuxostat Non-Inferior to Allopurinol in Reduction of MACE but Increases Mortality
In a recent article, published in The New England Journal of Medicine, the rates of major cardiovascular events with febuxosat were similar to allopurinol in patients with gout and concomitant…